Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBM reform push heats up Congress is ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

A Trump-appointed Federal Trade Commission (FTC) commissioner, for example ... address drug rebate amounts, and crack down on pharmacy benefit managers. If the IRA is not repealed, it is anticipated ...

At the top of the list are pharmacy benefit managers and the roadblocks they create for patients to access and afford necessary medications. Fortunately, since my diagnosis of Sjogren's disease, there ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...